2013 to 2022 Saw Increase in Group A Streptococcal Infections
Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents
17 Modifiable Risk Factors Shared by Stroke, Dementia, and Late-Life Depression
Authors say these factors can inform steps individuals can take to lower their risks for age-related brain diseases
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022
All-Cause Mortality Increased From 2020 to 2021 Nationwide
Increase was slower in Medicaid expansion states, resulting in net decrease from 2018-2019 to 2021-2022
Risk for Long COVID Lower in Pregnant Individuals
Findings seen compared with matched, nonpregnant women
Low LDL-C Levels Linked to Reduced Risk for Dementia
Statin use linked to reduction in risks for all-cause dementia and Alzheimer disease-related dementia
Only Half of U.S. Adults Can Afford Health Care and Prescriptions
Rate of unaffordability increased significantly among Black, Hispanic, and lower-income individuals
mHealth-Supported Intervention Boosts Physical Activity in Adults With Newly Diagnosed Diabetes
Authors say the intervention warrants evaluation in a randomized controlled trial
Rural-Urban Differences Seen in Cardiometabolic Risk Factors, CVD
Disparities greatest among younger adults and almost entirely explained by social risk factors
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes
Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date
